glp-1 mounjaro Is the Same as Ozempic GLP-1 Weight Loss Treatments: Ozempic,
Description
These figures represent a substantial growth: 33-40% since 2018, a stark contrast to the more modest increases of 7-10% seen in the previous five years
Patients often interpret early findings as guaranteed outcomes, which can lead to unrealistic expectations
Circulation 2023
To be market-worthy, the drug needed to remain active 24 hours a day, remain physically stable for long periods of time and be as or more potent than native GLP-1
By increasing and prolonging active incretin levels, JANUVIA increases insulin release and decreases glucagon levels in the circulation in a glucose-dependent manner
